Drugs / Novalin
last change Sep 2018 re-read 9 days ago

Novalin

Developed for
type 2 diabetes mellitus
Investigated by
Maya Guglin

Trials 1

20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT02694289 Nov 2016 → Sep 2018 type 2 diabetes mellitus Maya Guglin Withdrawn No outcome recorded Stop: Enrollment

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Novalin “eg. Humulin, Lantus, Novalin” NCT02694289 ↗